Search

everythinglearnresearchcommunity

for

Search:↓

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Most patients improved with oral contraceptives, but some needed additional treatment.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.